Evommune Inc. – Filings and Transcripts

NYSE: EVMN
Share price (8/12/26): $14.12
Market cap (8/12/26): $512 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Point72 Asset Management, L.P.

Kirsch Arthur S

Patel Jeegar Pravinkumar

Drew Janice Suzann

News Filter

Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis

Announces Top-Line Results From EVO756 Phase 2b Trial in Moderate-To-Severe Chronic Spontaneous Urticaria

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Business Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission